Animal Biotechnology Market Size, Share, By Product Type (Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives), By Application (Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others), By Animal Type (Companion, Livestock), By End-user (Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others), and By Region - Trends, Analysis and Forecast till 2034

Animal biotechnology market size was valued at USD 28.36 Billion in 2024 and is expected to reach USD 64.75 Billion by 2034, growing at a CAGR of 9.5%.

Animal biotechnology is considered a fast-growing field of science that manipulates advanced techniques aimed at the genetic material of animals for several purposes. The steep growth of this emerging industry in the recent past has been due to progress in molecular biology, genomics, and reproductive technologies. Further, the diversity characterizes the market through the technology carried out in agricultural production, pharmaceutical development, and environmental conservation. The ability of the animal biotechnology market to enhance agricultural productivity is undoubtedly one of its fundamental driving forces. Genetic manipulation enables animals—like transgenic livestock—to produce more meat, milk, or eggs with better and more desirable nutritional values. For example, a line of transgenic cows has been developed to produce milk containing human proteins to treat certain human diseases, such as cystic fibrosis.

Further, animal biotechnology can breed disease-resistant livestock with fewer antibiotics, improving animal welfare. The other significant use of animal biotechnology is in pharmaceutical development. Transgenic animals have been used to produce therapeutic proteins like insulin and growth factors, which may be difficult or very expensive to obtain through other means. Animal models are integral to drug discovery and development, as they allow for studies on the efficacy and safety of new drugs. With state-of-the-art genetic engineering techniques, it is possible for investigators today to come up with animal models that most resemble human diseases and permit causal insights into disease processes and treatment options.

Environmental conservation is another critical area where animal biotechnology is leaving its mark. In that regard, genetically altered animals can be utilized to control invasive species, protect endangered species, and enhance ecosystem health. There are already transgenic mosquitoes that cause a reduction in the population of mosquitoes that spread diseases like malaria and other vector-borne diseases. Moreover, biotechnological technologies in animals can also be used to formulate bioremediation techniques by using organisms to clean up environmental pollutants. Although having huge promising potential, the animal biotechnology market has a number of problems. There are ethical concerns over the development and Technology of genetically modified animals that have resulted in public debates and regulatory hurdles. There are also the risks that genetic material might pose to the environment when such organisms are released. Added to this is the high research and development cost, coupled with the complicated regulatory environment, which badly affects innovation and commercialization. The outlook for the animal biotechnology market also looks bright. Further technological developments, coupled with increasing interest in more sustainable and effective ways of solving many pressing global issues, point to growth potential in the market. When researchers and policymakers get around the more significant ethical and regulatory barriers to using animal biotechnology, potential gains from it, such as in agriculture, medicine, or the conservation of the environment, will likely be realized more and more.

                For More Report Details, Download Free Sample PDF

Key Drivers of Target Market:

Growing Demand for Animal-Derived Products

• As the global demand for meat, dairy, and other animal products increases, animal biotechnology can enhance productivity and feed efficiency and mitigate the negative environmental impact of animal farming, meeting such rising demand sustainably.

Animal Health and Disease Management

• Biotechnology enhances animal health by developing vaccines, diagnostics, and therapeutic interventions. Successful production of either transgenic animals that are more resistant to disease conditions or the creation of biopharmaceuticals through animal models will significantly help control zoonotic diseases, reduce dependence on antibiotics, and ensure better animal welfare.

Restrains:

High Cost of Treatment

• A lot of research, development, and regulatory approval are required to create a genetically engineered animal or a biotechnology product, which is costly. On the other hand, the large costs incurred by these processes, with the added uncertainty of successful commercialization, may dissuade smaller companies and startups from entering the competition. Moreover, the necessity of large-scale infrastructure and specialized expertise adds to the financial burden.

Opportunities:

Precision Breeding and Gene Editing

• The discovery of precision breeding and gene editing techniques, such as CRISPR-Cas9, offers immense opportunities to the animal biotechnology market. These technologies make it possible to change specific genes with an eye on producing animals possessing certain characteristics or traits, like disease resistance, growth rate improvement, and adding more nutritional value. Precision breeding has enormous potential to help address global food security challenges and reduce the environmental impact of animal agriculture.

The market is segmented based on Product Type, Application, Animal Type, End-User, and Region.

Product Type Insights:

• Diagnostic Testing: Diagnostic testing will enable the identification of animal diseases, pathogens, and genetic traits that the animal biotechnology market will lead to. The tests may include molecular diagnostics manifested through PCR and RT-PCR, immunodiagnostics by ELISA, and other advanced technologies, including new-generation sequencing. The diagnostic tests form the basis of timely conduct and management of diseases, both in livestock and companion animals. This further allows timely intervention and a reduction in the spread of infectious diseases.
• Vaccines: vaccines are yet another major product in the animal biotechnology market; they are helpful in preventing infectious diseases in animals. These can generally be live, attenuated, inactivated, subunit, or recombinant vaccines and variously prevent diseases such as rabies, avian influenza, or foot-and-mouth disease. The efficacy and safety of vaccines developed with the help of biotechnology tools—such as gene-based vaccines—will be paramount for better disease control in animals.
• Drugs: Biotechnology has introduced a revolution in developing animal drugs—they may be antibiotics, antiparasitics, and antivirals. Regarding the above, these represent treatments of overall animal diseases and ways to enhance their life. With the help of biotechnology advancements in manufacturing drugs, it became possible to make these treatments much more specific and compelling, thus reducing the risks of side effects and the formation of resistance. This also involves biopharmaceuticals, which are classified in such a way due to biological sources of origination and iodine in treating complicated animal health conditions.
• Reproductive and Genetic Products: These are biotechnologically derived products associated with animal reproduction by enhancing genetic heritage. For instance, artificial insemination, embryo transfer, or even cloning are all biotechnological applications implemented to increase reproductive efficiency and genetic traits of animals. Genetic engineering tools and CRISPR have also been applied to develop valuable traits in genetically modified animals, from disease resistance to enhanced productivity and tolerance to environmental conditions.
• Feed additives: this include probiotics, prebiotics, enzymes, and amino acids, increasing animals' nutrition, digestion, and health. The selected additives are primarily developed to boost growth, stimulate immunity principles, and act against diseases in livestock, hence increasing the productivity level and sustainability of animal farming.

Application insights:

• Diagnosis of Animal Diseases: This application is concerned with using biotechnology to detect and diagnose animal systems in the spread of a disease of either infectious or genetic origin. The more advanced the diagnosis with these tools, the more it can detect diseases at the early stage, hence providing the benefit of immediate and timely treatment to avoid outbreaks. This is crucial for food safety and retaining good health in animals, especially when livestock is part of the business.
• Treatment of Animal Disease: Biotechnology has played a significant role in developing new and innovative drugs, biologics, and treatments for animal diseases. These are meant for the targeted pathogens or conditions; consequently, it has increased the recovery rates and reduced mortality. This application also comprises the use of biopharmaceuticals and gene therapy in the treatment, which is related to complex diseases, and it is cumbersome to use the tools of conventional means.
• Preventive Care of animals: Any vaccines, nutritional supplements, or biotechnological preparations that help prevent disease and maintain an animal's health status are included under preventive care. These preventive measures are crucial in livestock management because a disease outbreak can be associated with severe economic losses. Regarding companion animals, preventive care revolves around essential vaccinations and regular checks.
• Drug Development: This application includes investigations into using biotechnological methods to develop new drugs and therapies for animals, including new, more effective antibiotics, antivirals, and other treatments with fewer side effects. In addition, biotechnology targets precision medicine for animals—in other words, treatments applied to an animal's individual setting according to genotyping or disease status.
• Other: this uses of biotechnology in animal management and health include lobbying to adopt animal breeding programs, manufacturing animal products, and environmental monitoring procedures. All help in improving the general welfare, productivity, and sustainability of animal farming. Type of Animal:

Animal type insights:

• Companion Animals: This could be one of the primary focuses of the animal biotechnology market, since it deals with companion animals, including dogs, cats, and horses. Health, life span, and humane life for pets are margins to which products and services in this specific segment are trying to promote to offer advanced diagnostics, treatments, vaccines, and preventive care according to particular pet needs. Demand in this segment is driven by growing pet ownership and increasing awareness of pet health.
• Livestock: Another major application of the animal biotechnology market changes the way people have been involved in improving the management of diseases, reproductive efficiency, and productivity-enhancing livestock. Vaccines, diagnostic tests, and feed additives are all used to maintain the health and productivity of livestock, thereby improving food security and reducing the environmental impacts of animal farming.

End-User insights:

• Laboratories:  this is essential end-use sector of the animal biotechnology market. They are engaged in research, diagnostics, and developing biotechnological products for the market. They are involved in genetic testing and the development of vaccines and drugs. Research laboratories in universities, government institutions, and private companies have crucial work in advancing biotechnological applications concerning animal health.
• Point-of-Care Testing/In-house Testing: Point-of-care testing and in-house testing facilities are increasingly being utilized in veterinary service areas, enabling the immediate availability of a diagnostic test result. These facilities have an increased potential to quickly serve animals for diagnosis and treatment, ensuring better patient outcomes with less time wasted on lab referrals that result in more specialized tests. Having such in-house test areas is helpful for rural or less accessible areas where access to extensive laboratories is problematic.
• Veterinary Hospitals and Clinics: Veterinary hospitals and clinics are designed to use animal biotechnology products and services primarily. Diagnostic tests, vaccines, drugs, and preventive care products for companion animals and livestock are extensively used in all such clinics and hospitals. Surgical procedures, emergency treatments, and ongoing health management are also carried out in these facilities.
• Others: This category includes other end users providing such services as animal shelters, research, and governmental agencies involved in animal health management. Such organizations could use biotechnology to monitor diseases, animal welfare programs, and public health about diseases of animals.

Regional insights:

• North America: this is one of the leading regions in this market, with significant investments drawn and advanced research through the stringency of regulatory frameworks and policies about animal health care. The United States and Canada are the key contributors to this market, with major investments being made in companion and livestock species. Other major canine countries in this region are endowed with strong ownership rates or significant livestock industries, thus guaranteeing a sustainable market demand for products from animal biosciences.
• Europe: Europe is an established animal biotechnology market, supported with robust government regulations, research institutions, and a focus on animal welfare. Countries like Germany, the UK, and France take a good share of the market in this respect. The region's mainstream emphasis on sustainable farming and animal health drives adaptation to biotechnological solutions.
• Asia-Pacific: The Asia-Pacific region is one of the growing markets for animal biotechnology. Increasing livestock farming, raising consumer awareness of animal health, and, subsequently, pet ownership are propelling the growth in this market. Important contributing countries are China, India, and Australia. Increasing agriculture in this region and investments in biotechnology will thus drive this market.
• Latin America: an evolving market for animal biotechnology, is developing, particularly within the livestock production segment. Concerning this, some of the key countries in the region are Brazil and Argentina, which are seeking an increase in the productivity of their livestock industry and a solution to disease problems in the agriculture sector. The region's importance on increased food security and export-driven livestock industries supports the demand for products from this industry.
• Middle East & Africa: The Middle East and Africa region is characterized by very low access to quality veterinary services and the prevalence of most of the region's diseases. However, the market grows with increased investments toward better food security in agriculture. In this regard, research in biotechnology targeting livestock productivity improvement and disease management affecting this region's animal and human populations is underway.

Animal Biotechnology Market Report Scope:

Attribute	Details
Market Size 2024	USD 28.36 Billion
Projected Market Size 2034	USD 64.75 Billion
CAGR Growth Rate	9.5%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	Product Type- Diagnostics Tests, Vaccines, Drugs, Reproductive and Genetic, Feed Additives Application- Diagnosis of Animal Diseases, Treatment of Animal Diseases, Preventive Care of Animals, Drug Development, Others Animal Type- Companion, Livestock End-user- Laboratories, Point-of-Care Testing/In-house Testing, Veterinary Hospitals & Clinics, Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Product Type, Application, Animal Type, End-User, and Region.

Segmentation:

By Product Type:

• Diagnostics Tests
• Vaccines
• Drugs
• Reproductive and Genetic
• Feed Additives

By Application:

• Diagnosis of Animal Diseases
• Treatment of Animal Diseases
• Preventive Care of Animals
• Drug Development
• Others

By Animal Type:

• Companion
• Livestock

By End-User:

• Laboratories
• Point-of-Care Testing/In-house Testing
• Veterinary Hospitals & Clinics
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Animal Biotechnology Market include Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health, Cargill Animal Nutrition, BASF SE, Syngenta AG, Thermo Fisher Scientific Inc., Genus PLC, Neogen Corporation, Alltech Inc., IDEXX Laboratories Inc., Aratana Therapeutics Inc., Animal Genetics Inc., Kemin Industries Inc.

                   To Access More Companies, Request Free Sample Report

• In August 2024, New Livestock Improvements with CRISPR, a Team of scientists at one of the largest biotechnology companies, succeeded in developing a CRISPR-based technology to increase livestock's resistance to diseases. This innovation is said to further animal health and productivity while reducing the need for antibiotics and other treatments.
• In July 2024, Animal Cell Line Development Breakthrough, a breakthrough in developing stable, high-yield animal cell lines for the production of pharmaceuticals was announced by a leading biotechnology company. This breakthrough is expected to drastically simplify the process of manufacturing vaccines and other therapeutic proteins.
• In June 2024, Nonagricultural biotechnology company launched genetically modified crops to improve the nutritional value of livestock feed. The company claims this will result in better feed efficiency and animal growth rates.

• Zoetis, Inc.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Merck Animal Health
• Elanco Animal Health Incorporated
• Boehringer Ingelheim Animal Health
• Cargill Animal Nutrition
• BASF SE
• Syngenta AG
• Thermo Fisher Scientific Inc.
• Genus PLC
• Neogen Corporation
• Alltech Inc.
• IDEXX Laboratories Inc.
• Aratana Therapeutics Inc.
• Animal Genetics Inc.
• Kemin Industries Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By Animal Type
  • Market Snippet, By End-User
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, By Product Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Diagnostics Tests
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Vaccines
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Drugs
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Reproductive and Genetic
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Feed Additives
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Diagnosis of Animal Diseases
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Treatment of Animal Diseases
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Preventive Care of Animals
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Drug Development
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Animal Type, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Companion
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Livestock
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Laboratories
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Point-of-Care Testing/In-house Testing
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Veterinary Hospitals & Clinics
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Others
  • Overview
  • Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)

• Overview
  • Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Animal Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Zoetis Inc.
• Merck Animal Health
• Elanco Animal Health Incorporated
• Boehringer Ingelheim Animal Health
• Cargill Animal Nutrition
• BASF SE
• Syngenta AG
• Thermo Fisher Scientific Inc.
• Genus PLC
• Neogen Corporation
• Alltech Inc.
• IDEXX Laboratories Inc.
• Aratana Therapeutics Inc.
• Animal Genetics Inc.
• Kemin Industries Inc.

The Last Word

• Future Impact
• About Us
• Contact